首页 > 最新文献

Clinica e Investigacion en Ginecologia y Obstetricia最新文献

英文 中文
Conceptos de criobiología y fisiología ovárica en la preservación de la fertilidad 生育力保存中的低温生物学和卵巢生理学概念
IF 0.1 Q4 Medicine Pub Date : 2024-02-23 DOI: 10.1016/j.gine.2024.100948
M. Méndez , Y. Cívico , G. Casals

Cryobiology focuses on understanding how biological materials react to very low temperatures. This field has experienced significant advances, particularly in the field of assisted reproduction, where programs have been developed to preserve fertility. These developments are of critical importance for those exploring alternatives in fertility and gamete preservation. Fertility preservation aims to protect a person's reproductive capacity under various health conditions, medical treatments, and social reasons that may compromise it. Accepted techniques for human fertility preservation include the cryopreservation of gametes and embryos. There is growing promising evidence on different experimental techniques within this field, such as cryopreservation of gonadal tissue or in vitro maturation strategies, as well as new methodologies in cryogenic protocols that will optimize results and mark a turning point in the field of assisted reproduction. This work aims to explore the current state-of-the-art strategies offered to women in the context of fertility preservation, review advances in cryobiology, and its role in the evolution of this area.

低温生物学侧重于了解生物材料在极低温度下的反应。这一领域已经取得了重大进展,尤其是在辅助生殖领域,已经开发出保存生育能力的方案。这些发展对于那些探索生育力和配子保存替代方法的人来说至关重要。生育力保存的目的是在各种健康状况、医疗手段和社会原因下,保护一个人的生殖能力。公认的人类生育能力保存技术包括配子和胚胎的冷冻保存。越来越多的证据表明,这一领域的不同实验技术(如性腺组织低温保存或体外成熟策略)以及低温方案中的新方法将优化结果,并标志着辅助生殖领域的转折点。这项工作旨在探索目前在生育力保存方面为妇女提供的最先进策略,回顾低温生物学的进展及其在该领域发展中的作用。
{"title":"Conceptos de criobiología y fisiología ovárica en la preservación de la fertilidad","authors":"M. Méndez ,&nbsp;Y. Cívico ,&nbsp;G. Casals","doi":"10.1016/j.gine.2024.100948","DOIUrl":"https://doi.org/10.1016/j.gine.2024.100948","url":null,"abstract":"<div><p>Cryobiology focuses on understanding how biological materials react to very low temperatures. This field has experienced significant advances, particularly in the field of assisted reproduction, where programs have been developed to preserve fertility. These developments are of critical importance for those exploring alternatives in fertility and gamete preservation. Fertility preservation aims to protect a person's reproductive capacity under various health conditions, medical treatments, and social reasons that may compromise it. Accepted techniques for human fertility preservation include the cryopreservation of gametes and embryos. There is growing promising evidence on different experimental techniques within this field, such as cryopreservation of gonadal tissue or in vitro maturation strategies, as well as new methodologies in cryogenic protocols that will optimize results and mark a turning point in the field of assisted reproduction. This work aims to explore the current state-of-the-art strategies offered to women in the context of fertility preservation, review advances in cryobiology, and its role in the evolution of this area.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"51 2","pages":"Article 100948"},"PeriodicalIF":0.1,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139941622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-elective caesarean section risk assessment using Machine Learning techniques 利用机器学习技术进行非选择性剖腹产风险评估
IF 0.1 Q4 Medicine Pub Date : 2024-02-22 DOI: 10.1016/j.gine.2024.100949
L. López-Mendizábal , C. Varea , A. Berlanga , M.A. Patricio , J.M. Molina , J.L. Bartha

Background

The sustained increase and the disparities in the rate of caesarean deliveries (CS) pose a public health challenge. Optimising the use of CS is of global concern and a challenge for public health. Machine Learning (ML) techniques can assist clinicians in decision-making, improving treatment modalities and patient outcomes.

Methods

Original data correspond to the 41,037 deliveries that took place at La Paz University Maternity Hospital (Madrid, Spain) between 2010 and 2018. Machine Learning (ML) model algorithm Random Forest (RF) was performed to determine the risk of CS. The first analysis was Mean Decrease Accuracy carried out on 50 permutations. The second analysis was ceteris-paribus and partial-dependence profiles.

Results

The RF models obtained identify a higher risk of CS delivery in multiple gestations, macrosomic foetuses and in those with prolonged gestation associated with other maternal–foetal characteristics. Results deny the consideration that older nulliparous mothers represent a specific obstetrtic risk goup.

Conclusions

ML techniques can be very useful in identifying risk factors to be addressed to optimise the number of CS. Macrosomia prevention programmes, reduction in the rate of multiple pregnancies or finishing pregnancy before the onset of risks associated with prolonged pregnancy may be ways to optimise the number of CS.

背景剖腹产率(CS)的持续增长和差异对公共卫生构成了挑战。优化剖腹产的使用是全球关注的问题,也是公共卫生面临的挑战。机器学习(ML)技术可以帮助临床医生做出决策,改善治疗方式和患者预后。方法原始数据对应的是 2010 年至 2018 年期间在拉巴斯大学产科医院(西班牙马德里)进行的 41,037 例分娩。采用机器学习(ML)模型算法随机森林(RF)确定CS风险。第一项分析是对 50 次排列进行的平均下降准确率分析。结果所获得的 RF 模型发现,多胎妊娠、巨大胎儿以及与其他母胎特征相关的妊娠期延长的胎儿发生 CS 分娩的风险较高。结论ML 技术在确定风险因素以优化 CS 数量方面非常有用。预防巨大儿计划、降低多胎妊娠率或在与妊娠时间过长相关的风险出现之前结束妊娠,可能是优化剖宫产次数的方法。
{"title":"Non-elective caesarean section risk assessment using Machine Learning techniques","authors":"L. López-Mendizábal ,&nbsp;C. Varea ,&nbsp;A. Berlanga ,&nbsp;M.A. Patricio ,&nbsp;J.M. Molina ,&nbsp;J.L. Bartha","doi":"10.1016/j.gine.2024.100949","DOIUrl":"https://doi.org/10.1016/j.gine.2024.100949","url":null,"abstract":"<div><h3>Background</h3><p>The sustained increase and the disparities in the rate of caesarean deliveries (CS) pose a public health challenge. Optimising the use of CS is of global concern and a challenge for public health. Machine Learning (ML) techniques can assist clinicians in decision-making, improving treatment modalities and patient outcomes.</p></div><div><h3>Methods</h3><p>Original data correspond to the 41,037 deliveries that took place at La Paz University Maternity Hospital (Madrid, Spain) between 2010 and 2018. Machine Learning (ML) model algorithm Random Forest (RF) was performed to determine the risk of CS. The first analysis was Mean Decrease Accuracy carried out on 50 permutations. The second analysis was ceteris-paribus and partial-dependence profiles.</p></div><div><h3>Results</h3><p>The RF models obtained identify a higher risk of CS delivery in multiple gestations, macrosomic foetuses and in those with prolonged gestation associated with other maternal–foetal characteristics. Results deny the consideration that older nulliparous mothers represent a specific obstetrtic risk goup.</p></div><div><h3>Conclusions</h3><p>ML techniques can be very useful in identifying risk factors to be addressed to optimise the number of CS. Macrosomia prevention programmes, reduction in the rate of multiple pregnancies or finishing pregnancy before the onset of risks associated with prolonged pregnancy may be ways to optimise the number of CS.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"51 3","pages":"Article 100949"},"PeriodicalIF":0.1,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139943023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fertility preservation in endometriosis: Review of current evidence and best practices 子宫内膜异位症的生育力保护:当前证据和最佳实践综述
IF 0.1 Q4 Medicine Pub Date : 2024-02-17 DOI: 10.1016/j.gine.2024.100951
M. Carbonell, M.A. Perelló, J. Herrero

In recent decades, the field of female fertility preservation has experienced substantial growth. Reliable techniques such as cryopreservation of oocytes and ovarian tissue have emerged, along with more established methods such as embryo freezing. Among the group of patients who can benefit from these new techniques are patients with endometriosis, a common disease capable of compromising ovarian reserve and fertility prospects. Unfortunately, comprehensive recommendations for fertility preservation in patients with endometriosis are still lacking.

This narrative review comprehensively explores fertility preservation in patients with endometriosis, using a range of relevant literature, including available national and international guidelines. Additionally, it explains the weight of several factors that contribute to the decision-making process for fertility preservation, including age, severity of endometriosis, ovarian reserve, and previous or future surgery.

This manuscript summarizes available recommendations that provide guidance for this vital but challenging aspect of reproductive medicine. Underlines the need for personalized care for patients with an early diagnosis of endometriosis and initial medical treatment to try to reduce the deterioration of ovarian reserve and emphasizes the importance of research to refine fertility preservation strategies in people with endometriosis.

近几十年来,女性生育力保存领域取得了长足的发展。卵母细胞和卵巢组织冷冻保存等可靠的技术以及胚胎冷冻等更成熟的方法已经出现。子宫内膜异位症是一种可损害卵巢储备和生育前景的常见疾病,子宫内膜异位症患者是这些新技术的受益群体之一。这篇叙述性综述利用一系列相关文献,包括现有的国家和国际指南,全面探讨了子宫内膜异位症患者的生育力保存问题。此外,它还解释了影响生育力保留决策过程的几个因素的权重,包括年龄、子宫内膜异位症的严重程度、卵巢储备以及之前或未来的手术。本手稿总结了现有的建议,为生殖医学中这一重要但具有挑战性的方面提供了指导。本手稿总结了现有的建议,为生殖医学这一重要但具有挑战性的方面提供指导。强调需要为早期诊断出子宫内膜异位症的患者提供个性化护理,并进行初步治疗,以尽量减少卵巢储备功能的衰退,同时强调研究完善子宫内膜异位症患者生育力保存策略的重要性。
{"title":"Fertility preservation in endometriosis: Review of current evidence and best practices","authors":"M. Carbonell,&nbsp;M.A. Perelló,&nbsp;J. Herrero","doi":"10.1016/j.gine.2024.100951","DOIUrl":"https://doi.org/10.1016/j.gine.2024.100951","url":null,"abstract":"<div><p>In recent decades, the field of female fertility preservation has experienced substantial growth. Reliable techniques such as cryopreservation of oocytes and ovarian tissue have emerged, along with more established methods such as embryo freezing. Among the group of patients who can benefit from these new techniques are patients with endometriosis, a common disease capable of compromising ovarian reserve and fertility prospects. Unfortunately, comprehensive recommendations for fertility preservation in patients with endometriosis are still lacking.</p><p>This narrative review comprehensively explores fertility preservation in patients with endometriosis, using a range of relevant literature, including available national and international guidelines. Additionally, it explains the weight of several factors that contribute to the decision-making process for fertility preservation, including age, severity of endometriosis, ovarian reserve, and previous or future surgery.</p><p>This manuscript summarizes available recommendations that provide guidance for this vital but challenging aspect of reproductive medicine. Underlines the need for personalized care for patients with an early diagnosis of endometriosis and initial medical treatment to try to reduce the deterioration of ovarian reserve and emphasizes the importance of research to refine fertility preservation strategies in people with endometriosis.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"51 2","pages":"Article 100951"},"PeriodicalIF":0.1,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139898684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preservación de la fertilidad en personas transgénero del espectro masculino. Revisión narrativa de la literatura 男谱变性人的生育力保存。文献综述
IF 0.1 Q4 Medicine Pub Date : 2024-02-15 DOI: 10.1016/j.gine.2024.100950
A. Borrás Capó , M. Méndez , M. Mora Porta , D. Manau Trullàs

Gender affirming hormone therapy (GAHT) in transmasculine people (individuals who identify as men or on the masculine spectrum and were assigned female sex at birth) makes it possible to modify the secondary sexual characteristics of the sex assigned at birth, thus alleviating the symptoms of gender dysphoria, during the process called transition. However, it is necessary to highlight that the effect of GAHT on long-term fertility and its potential gonadotoxic effects are currently unknown. Knowledge of the effects of testosterone on fertility and reproduction has increased recently, whilst the request for comprehensive reproductive counselling and the option of performing fertility preservation (FP) techniques have increased exponentially in recent years, leading to profound changes in the clinical management of this population.

In this review, we analyzed all the information published regarding the effect of GAHT on reproduction and the FP techniques available in this group, mainly oocyte vitrification. In addition, we carry out an exhaustive analysis of the reproductive results published to date after the use of preservation techniques and present the latest laboratory advances concerning ovarian tissue cryopreservation and in vitro oocyte maturation, together with future options in the transmasculine people.

对跨男性化人群(出生时被指定为女性的男性或男性化人群)进行性别确认激素疗法(GAHT),可以改变出生时指定性别的第二性征,从而在称为过渡的过程中减轻性别焦虑症的症状。不过,有必要强调的是,目前尚不清楚性别雌激素对长期生育能力的影响及其潜在的性腺毒性作用。最近,人们对睾酮对生育和生殖的影响有了更多的了解,同时,近年来对综合生殖咨询的要求和进行生育力保存(FP)技术的选择也成倍增加,从而导致这一人群的临床管理发生了深刻的变化。在这篇综述中,我们分析了已发表的有关 GAHT 对生殖的影响和这一群体可用的 FP 技术(主要是卵细胞玻璃化技术)的所有信息。此外,我们还详尽分析了迄今为止发表的使用保存技术后的生殖结果,并介绍了有关卵巢组织冷冻保存和体外卵母细胞成熟的最新实验室进展,以及跨膜人群的未来选择。
{"title":"Preservación de la fertilidad en personas transgénero del espectro masculino. Revisión narrativa de la literatura","authors":"A. Borrás Capó ,&nbsp;M. Méndez ,&nbsp;M. Mora Porta ,&nbsp;D. Manau Trullàs","doi":"10.1016/j.gine.2024.100950","DOIUrl":"https://doi.org/10.1016/j.gine.2024.100950","url":null,"abstract":"<div><p>Gender affirming hormone therapy (GAHT) in transmasculine people (individuals who identify as men or on the masculine spectrum and were assigned female sex at birth) makes it possible to modify the secondary sexual characteristics of the sex assigned at birth, thus alleviating the symptoms of gender dysphoria, during the process called transition. However, it is necessary to highlight that the effect of GAHT on long-term fertility and its potential gonadotoxic effects are currently unknown. Knowledge of the effects of testosterone on fertility and reproduction has increased recently, whilst the request for comprehensive reproductive counselling and the option of performing fertility preservation (FP) techniques have increased exponentially in recent years, leading to profound changes in the clinical management of this population.</p><p>In this review, we analyzed all the information published regarding the effect of GAHT on reproduction and the FP techniques available in this group, mainly oocyte vitrification. In addition, we carry out an exhaustive analysis of the reproductive results published to date after the use of preservation techniques and present the latest laboratory advances concerning ovarian tissue cryopreservation and in vitro oocyte maturation, together with future options in the transmasculine people.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"51 2","pages":"Article 100950"},"PeriodicalIF":0.1,"publicationDate":"2024-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139743910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of hopelessness in patients with endometriosis 评估子宫内膜异位症患者的绝望情绪
IF 0.1 Q4 Medicine Pub Date : 2024-01-13 DOI: 10.1016/j.gine.2023.100936
M.d.P. Marín Sánchez , O. Carratalá Pérez , A. Martínez Gómez , R. Oliva Sánchez , A. Nieto Díaz

Purpose

To explore the prevalence of hopelessness in patients diagnosed with endometriosis and how it may influence their relationships.

Material and methods

Prospective–descriptive study among patients with a clinical and/or anatomopathological diagnosis of endometriosis. Demographic data (age, religion, educational level, marital status, occupation, etc.) and pain data have been processed. Pain associated with endometriosis has been evaluated with an analogue scale of pain. The Beck Hopelessness Scale (BHS) was used to determine the level of hopelessness. The results have been classified into 0–3 normal; 4–8 mild; 9–14 moderate and 15–20 severe. SPSS Statistics 26 has been used and the statistical significance has been stipulated at p < 0.05.

Results

One hundred and ten patients have been recruited with an average age of 39.8 ± 7.09 years. The average on the Beck Hopelessness Scale is 5.08 with a SD 3.14. In our sample, we obtained that 38.2% of women experienced some level of hopelessness at the time the questionnaire was completed (mild = 28.2%, moderate = 9.1%, severe = 0.9%). We found a significant relation between hopelessness and low income but not with regard to education, employment status or marital status.

Regarding the pain experienced and its relation with hopelessness, we found that it was significantly connected to pain during urination and dyspareunia and not to chronic pelvic pain dysmenorrhea and dyschezia.

Conclusion

Four out of ten patients with endometriosis experience hopelessness, mostly mildly. This hopelessness is influenced by demographic factors such as income level and also pain, specifically pain during intercourse and during urination.

材料和方法对临床和/或解剖病理诊断为子宫内膜异位症的患者进行前瞻性描述性研究。对人口统计学数据(年龄、宗教信仰、教育程度、婚姻状况、职业等)和疼痛数据进行了处理。与子宫内膜异位症相关的疼痛已通过疼痛模拟量表进行了评估。贝克无望量表(Beck Hopelessness Scale,BHS)用于确定无望程度。结果分为 0-3 正常;4-8 轻度;9-14 中度和 15-20 重度。结果 共招募了 110 名患者,平均年龄为(39.8 ± 7.09)岁。贝克无望感量表的平均值为 5.08,标准差为 3.14。在我们的样本中,我们发现 38.2% 的女性在填写问卷时有一定程度的绝望感(轻度 = 28.2%,中度 = 9.1%,重度 = 0.9%)。关于所经历的疼痛及其与绝望情绪的关系,我们发现,绝望情绪与排尿疼痛和排便困难有明显关系,而与慢性盆腔痛经和月经不调没有明显关系。这种绝望感受收入水平等人口因素以及疼痛(尤其是性交痛和排尿痛)的影响。
{"title":"Evaluation of hopelessness in patients with endometriosis","authors":"M.d.P. Marín Sánchez ,&nbsp;O. Carratalá Pérez ,&nbsp;A. Martínez Gómez ,&nbsp;R. Oliva Sánchez ,&nbsp;A. Nieto Díaz","doi":"10.1016/j.gine.2023.100936","DOIUrl":"https://doi.org/10.1016/j.gine.2023.100936","url":null,"abstract":"<div><h3>Purpose</h3><p>To explore the prevalence of hopelessness in patients diagnosed with endometriosis and how it may influence their relationships.</p></div><div><h3>Material and methods</h3><p>Prospective–descriptive study among patients with a clinical and/or anatomopathological diagnosis of endometriosis. Demographic data (age, religion, educational level, marital status, occupation, etc.) and pain data have been processed. Pain associated with endometriosis has been evaluated with an analogue scale of pain. The Beck Hopelessness Scale (BHS) was used to determine the level of hopelessness. The results have been classified into 0–3 normal; 4–8 mild; 9–14 moderate and 15–20 severe. SPSS Statistics 26 has been used and the statistical significance has been stipulated at <em>p</em> <!-->&lt;<!--> <!-->0.05.</p></div><div><h3>Results</h3><p>One hundred and ten patients have been recruited with an average age of 39.8<!--> <!-->±<!--> <!-->7.09 years. The average on the Beck Hopelessness Scale is 5.08 with a SD 3.14. In our sample, we obtained that 38.2% of women experienced some level of hopelessness at the time the questionnaire was completed (mild<!--> <!-->=<!--> <!-->28.2%, moderate<!--> <!-->=<!--> <!-->9.1%, severe<!--> <!-->=<!--> <!-->0.9%). We found a significant relation between hopelessness and low income but not with regard to education, employment status or marital status.</p><p>Regarding the pain experienced and its relation with hopelessness, we found that it was significantly connected to pain during urination and dyspareunia and not to chronic pelvic pain dysmenorrhea and dyschezia.</p></div><div><h3>Conclusion</h3><p>Four out of ten patients with endometriosis experience hopelessness, mostly mildly. This hopelessness is influenced by demographic factors such as income level and also pain, specifically pain during intercourse and during urination.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"51 2","pages":"Article 100936"},"PeriodicalIF":0.1,"publicationDate":"2024-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139434418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impacto de la fragmentación del ADN espermático y la tecnología de microfluidos en los resultados de fecundación in vitro 精子 DNA 片段和微流控技术对试管婴儿结果的影响
IF 0.1 Q4 Medicine Pub Date : 2024-01-13 DOI: 10.1016/j.gine.2023.100937
S. Cívico Vallejos, Y. Cívico Vallejos, B. Hernández Dacruz

An accurate diagnosis in infertile patients is key to determine the treatment of choice in an assisted reproduction program. In the case of the male, the initial diagnosis is based on the result of the semen analysis. The semen analysis can detect problems related to the couple's infertility, but it is insufficient for the correct diagnosis of male infertility, since it does not predict the functional capacity of the spermatozoa. In recent years, multiple studies have appeared that relate sperm ADN integrity to fertility. At the same time, IVF laboratories have within their reach new methods of sperm selection, such as microfluidics, which would make it possible to reduce the degree of ADN fragmentation in the sample. In this paper we review the impact of sperm ADN fragmentation and the use of microfluidic devices on IVF outcomes based on a selection of relevant studies published up to February 2023.

对不育症患者进行准确诊断是确定辅助生殖方案中首选治疗方法的关键。就男性而言,最初的诊断是基于精液分析的结果。精液分析可以发现与夫妇不育有关的问题,但不足以正确诊断男性不育,因为它不能预测精子的功能能力。近年来,已有多项研究将精子 ADN 的完整性与生育能力联系起来。与此同时,试管婴儿实验室也有了新的精子选择方法,如微流体技术,从而有可能降低样本中 ADN 的破碎程度。在本文中,我们根据截至2023年2月发表的部分相关研究,回顾了精子ADN碎片和微流控设备的使用对试管婴儿结果的影响。
{"title":"Impacto de la fragmentación del ADN espermático y la tecnología de microfluidos en los resultados de fecundación in vitro","authors":"S. Cívico Vallejos,&nbsp;Y. Cívico Vallejos,&nbsp;B. Hernández Dacruz","doi":"10.1016/j.gine.2023.100937","DOIUrl":"https://doi.org/10.1016/j.gine.2023.100937","url":null,"abstract":"<div><p>An accurate diagnosis in infertile patients is key to determine the treatment of choice in an assisted reproduction program. In the case of the male, the initial diagnosis is based on the result of the semen analysis. The semen analysis can detect problems related to the couple's infertility, but it is insufficient for the correct diagnosis of male infertility, since it does not predict the functional capacity of the spermatozoa. In recent years, multiple studies have appeared that relate sperm ADN integrity to fertility. At the same time, IVF laboratories have within their reach new methods of sperm selection, such as microfluidics, which would make it possible to reduce the degree of ADN fragmentation in the sample. In this paper we review the impact of sperm ADN fragmentation and the use of microfluidic devices on IVF outcomes based on a selection of relevant studies published up to February 2023.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"51 2","pages":"Article 100937"},"PeriodicalIF":0.1,"publicationDate":"2024-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139434419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aplicación de la clasificación de Robson como método útil para estandarizar el manejo del parto. Un ejercicio que reduce la tasa de cesáreas 应用罗布森分类法作为标准化分娩管理的有效方法。降低剖腹产率的练习。
IF 0.1 Q4 Medicine Pub Date : 2024-01-09 DOI: 10.1016/j.gine.2023.100935
L. Pastor , R. Garcia-Jimenez , I. Valero , C. Borrero , L. Castro , J.A. Garcia-Mejido , J.A. Sainz Bueno

Background

Cesarean section rate is controversial and the Robson classification is a method for standardizing the evaluation of the causes of cesarean section. The aim of this study was to evaluate whether the measures to improve prenatal and intrapartum management implemented after the Robson classification evaluation lead to a decrease in the rate of cesarean sections without increasing the rates of neonatal and maternal morbidity and mortality.

Material and method

Quasi-experimental study before-after,between-2019 and 2020, including a total of 2181 patients with delivery at Hospital-Universitario-Valme(1027 patients in Group-2019, and 1154 patients in group-2020)..

Results

We observed that there was a statistically significant decrease in the cesarean section rate between 2019 and 2020 (21.0% vs 15.8%; p = 0.001) without the decrease being significant in any study subgroup. There was a lower rate of induced labor(29.3% vs 24.6%; p = 0.01), an increased rate of vaginal delivery (79.0% vs 84.2%; p = 0.001), both eutocic and instrumental deliveries (57.9% vs 60.3%; 21% vs 23.9%; p = 0.005) and a statistically significant decrease in the rate of cesarean sections due to failure of induction or non-progression of labor(34.7% vs 20.9%;p = 0.008). In inductions using the balloon-Cook we observed a decrease in the rate of cesarean section (45.3% versus 22.2% p = 0.001). We found a decrease in the percentage of admission to the Neonatal ICU (10.5% vs 7.6%; p = 0.016) and global neonatal morbidity(11.4% vs 8.2%; p = 0.013) without observing a difference in maternal outcomes.

Conclusions

The application of the Robson classification can be a useful method to identify groups that require the application of specific measures aimed at standardizing the management of these patients, thus allowing to reduce the rate of cesarean sections.

背景剖宫产率存在争议,罗布森分类法是对剖宫产原因进行标准化评估的一种方法。本研究旨在评估罗布森分类评估后实施的产前和产时管理改进措施是否会降低剖宫产率,同时不增加新生儿和孕产妇的发病率和死亡率。材料与方法在2019年和2020年之间进行了前后对比的准实验研究,共纳入了2181名在瓦尔米大学医院分娩的患者(2019年组1027名患者,2020年组1154名患者)。 结果我们发现,2019年和2020年之间的剖宫产率在统计学上有显著下降(21.0% vs 15.8%;P = 0.001),但在任何研究亚组中下降幅度都不大。引产率降低(29.3% vs 24.6%;p = 0.01),阴道分娩率上升(79.0% vs 84.2%;p = 0.001),顺产和器械助产率均上升(57.9% vs 60.3%;21% vs 23.9%;p = 0.005),因引产失败或产程未进展而进行剖宫产的比例有显著下降(34.7% vs 20.9%;p = 0.008)。在使用气囊库进行引产时,我们观察到剖宫产率有所下降(45.3% 对 22.2%; p = 0.001)。我们发现,新生儿重症监护室的入院率(10.5% 对 7.6%;P = 0.016)和新生儿总体发病率(11.4% 对 8.2%;P = 0.013)均有所下降,但孕产妇的预后并无差异。结论罗布森分类法的应用是一种有用的方法,可用于确定哪些群体需要采取特定措施来规范这些患者的管理,从而降低剖宫产率。
{"title":"Aplicación de la clasificación de Robson como método útil para estandarizar el manejo del parto. Un ejercicio que reduce la tasa de cesáreas","authors":"L. Pastor ,&nbsp;R. Garcia-Jimenez ,&nbsp;I. Valero ,&nbsp;C. Borrero ,&nbsp;L. Castro ,&nbsp;J.A. Garcia-Mejido ,&nbsp;J.A. Sainz Bueno","doi":"10.1016/j.gine.2023.100935","DOIUrl":"https://doi.org/10.1016/j.gine.2023.100935","url":null,"abstract":"<div><h3>Background</h3><p>Cesarean section rate is controversial and the Robson classification is a method for standardizing the evaluation of the causes of cesarean section. The aim of this study was to evaluate whether the measures to improve prenatal and intrapartum management implemented after the Robson classification evaluation lead to a decrease in the rate of cesarean sections without increasing the rates of neonatal and maternal morbidity and mortality.</p></div><div><h3>Material and method</h3><p>Quasi-experimental study before-after,between-2019 and 2020, including a total of 2181 patients with delivery at Hospital-Universitario-Valme(1027 patients in Group-2019, and 1154 patients in group-2020)..</p></div><div><h3>Results</h3><p>We observed that there was a statistically significant decrease in the cesarean section rate between 2019 and 2020 (21.0% vs 15.8%; p = 0.001) without the decrease being significant in any study subgroup. There was a lower rate of induced labor(29.3% vs 24.6%; p = 0.01), an increased rate of vaginal delivery (79.0% vs 84.2%; p = 0.001), both eutocic and instrumental deliveries (57.9% vs 60.3%; 21% vs 23.9%; p = 0.005) and a statistically significant decrease in the rate of cesarean sections due to failure of induction or non-progression of labor(34.7% vs 20.9%;p = 0.008). In inductions using the balloon-Cook we observed a decrease in the rate of cesarean section (45.3% versus 22.2% p = 0.001). We found a decrease in the percentage of admission to the Neonatal ICU (10.5% vs 7.6%; p = 0.016) and global neonatal morbidity(11.4% vs 8.2%; p = 0.013) without observing a difference in maternal outcomes.</p></div><div><h3>Conclusions</h3><p>The application of the Robson classification can be a useful method to identify groups that require the application of specific measures aimed at standardizing the management of these patients, thus allowing to reduce the rate of cesarean sections.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"51 2","pages":"Article 100935"},"PeriodicalIF":0.1,"publicationDate":"2024-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139399298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preservación de la fertilidad en el tumor ovárico borderline 边缘性卵巢肿瘤的生育力保护
IF 0.1 Q4 Medicine Pub Date : 2024-01-04 DOI: 10.1016/j.gine.2023.100933
S. Peón Muñoz

Borderline ovarian tumors (BOTs) are defined as “tumors of low malignant potential”. These are epithelial neoplasms that debut mainly in young women, and are usually diagnosed in the initial stages of the disease.

The main key to its treatment is surgery, thus compromising the fertility of the patient who has not fulfilled her reproductive desire. In general, the choice of surgery for BOTs should consider the characteristics of the tumor, the patient's fertility desires, and the extent of the disease. The decisions made in this regard must be individualized and advised by a multidisciplinary team.

Fertility preservation (FP) plays an important role in the management of these patients, and there are different strategies to improve and maintain their quality of life.

Reproductive counseling should be an integral part of clinical management, with risks and benefits carefully considered.

Given its low incidence, there is little literature on the matter, requiring well-designed prospective studies to address specific fertility problems both in the initial diagnosis and in recurrences of patients with BOTs.

边缘性卵巢肿瘤(BOTs)被定义为 "恶性程度较低的肿瘤"。这些肿瘤是上皮性肿瘤,主要在年轻女性中首发,通常在疾病的初期阶段被诊断出来。治疗的主要关键是手术,因此会影响尚未实现生育愿望的患者的生育能力。一般来说,BOT 手术的选择应考虑肿瘤的特点、患者的生育愿望和疾病的程度。生育力保护(FP)在这些患者的治疗中扮演着重要的角色,有不同的策略来改善和维持他们的生活质量,生殖咨询应该是临床治疗中不可或缺的一部分,并仔细考虑风险和益处。鉴于其发病率较低,这方面的文献很少,因此需要进行精心设计的前瞻性研究,以解决 BOTs 患者初诊和复发时的具体生育问题。
{"title":"Preservación de la fertilidad en el tumor ovárico borderline","authors":"S. Peón Muñoz","doi":"10.1016/j.gine.2023.100933","DOIUrl":"https://doi.org/10.1016/j.gine.2023.100933","url":null,"abstract":"<div><p>Borderline ovarian tumors (BOTs) are defined as “tumors of low malignant potential”. These are epithelial neoplasms that debut mainly in young women, and are usually diagnosed in the initial stages of the disease.</p><p>The main key to its treatment is surgery, thus compromising the fertility of the patient who has not fulfilled her reproductive desire. In general, the choice of surgery for BOTs should consider the characteristics of the tumor, the patient's fertility desires, and the extent of the disease. The decisions made in this regard must be individualized and advised by a multidisciplinary team.</p><p>Fertility preservation (FP) plays an important role in the management of these patients, and there are different strategies to improve and maintain their quality of life.</p><p>Reproductive counseling should be an integral part of clinical management, with risks and benefits carefully considered.</p><p>Given its low incidence, there is little literature on the matter, requiring well-designed prospective studies to address specific fertility problems both in the initial diagnosis and in recurrences of patients with BOTs.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"51 2","pages":"Article 100933"},"PeriodicalIF":0.1,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139100577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tratamiento médico del aborto del primer trimestre: igual eficacia, más eficiencia 头胎流产的药物治疗:同等效果,更有效率
IF 0.1 Q4 Medicine Pub Date : 2024-01-04 DOI: 10.1016/j.gine.2023.100934
A. Tomaizeh Gómez, A. Armijo Sánchez, J. Boned López, E. Arroyo Estevez

Background

Early pregnancy loss occurs in 10-20% of all clinical pregnancies, 85% being prior to week 12 of amenorrhea. Miscarriage entails a very significant burden on healthcare resources, reaching a national economic cost in the United Kingdom of £471 million per year (€533.06 million), a figure that can be extrapolated to other industrialized countries. According to a recent systematic review, there are no well-designed trials in first-trimester pregnancies that provide consolidated evidence on what is the best first-trimester abortion treatment method, and there are different studies that have tried to demonstrate cost reduction with contradictory results.

Material and methods

An observational, retrospective and longitudinal design study was carried out. 892 patients diagnosed with spontaneous abortion during the first trimester of pregnancy were reviewed, in the period between January 2013 and December 2016.

In our study, we wanted to evaluate the efficacy of vaginal misoprostol as a medical treatment for spontaneous abortion in the first trimester, in comparison with obstetric curettage-evacuator, and to quantify the difference in the costs of both procedures through a cost minimization study. costs.

Results

Of the 892 recruited patients, medical treatment with misoprostol was performed in 517 (57.95%) and surgical treatment by curettage in 375 (42.05%).

The effectiveness of medical treatment was 82% (426/517). With respect to surgical treatment the effectiveness of 100%. The success rate of medical treatment was higher in the subgroup of patients with incomplete abortion (92.9%), compared to the anembryonic gestation (85.7%) and delayed abortion (78.2%) groups.

Conclusions

The medical treatment of abortion is a safe management and accepted by the patients. The adequate selection of candidate patients leads to an increase in the success rate and a decrease in costs. In our study, an important total saving of €576,847.92 (37.14%) with respect to surgical treatment will be reduced. Given that the effectiveness is comparable and patient satisfaction is high, although it could be improved, we believe that with adequate information and homogenization of the applied treatment, it is safe.

背景在所有临床妊娠中,早期妊娠流产的发生率为 10-20%,其中 85% 发生在停经 12 周之前。流产对医疗资源造成了巨大的负担,在英国,每年的国民经济成本高达 4.71 亿英镑(5.3306 亿欧元),这一数字可以推断到其他工业化国家。根据最近的一项系统性综述,目前还没有针对第一胎妊娠的精心设计的试验为第一胎流产的最佳治疗方法提供综合证据,也有不同的研究试图证明成本的降低,但结果却相互矛盾。在研究中,我们希望评估阴道米索前列醇作为妊娠头三个月自然流产的药物治疗与产科刮宫-吸宫术的疗效对比,并通过成本最小化研究量化两种手术的成本差异。结果 在招募的 892 名患者中,517 人(57.95%)接受了米索前列醇药物治疗,375 人(42.05%)接受了刮宫手术治疗,药物治疗的有效率为 82%(426/517)。药物治疗的有效率为 82%(426/517),手术治疗的有效率为 100%。与胚胎妊娠组(85.7%)和延迟流产组(78.2%)相比,不完全流产患者分组的药物治疗成功率更高(92.9%)。适当选择候选患者可提高成功率并降低成本。在我们的研究中,与手术治疗相比,总共可节省 576847.92 欧元(37.14%)。鉴于疗效相当,患者满意度也很高,尽管还有待改进,但我们相信,只要有足够的信息和应用治疗的同质化,它是安全的。
{"title":"Tratamiento médico del aborto del primer trimestre: igual eficacia, más eficiencia","authors":"A. Tomaizeh Gómez,&nbsp;A. Armijo Sánchez,&nbsp;J. Boned López,&nbsp;E. Arroyo Estevez","doi":"10.1016/j.gine.2023.100934","DOIUrl":"https://doi.org/10.1016/j.gine.2023.100934","url":null,"abstract":"<div><h3>Background</h3><p>Early pregnancy loss occurs in 10-20% of all clinical pregnancies, 85% being prior to week 12 of amenorrhea. Miscarriage entails a very significant burden on healthcare resources, reaching a national economic cost in the United Kingdom of £471 million per year (€533.06 million), a figure that can be extrapolated to other industrialized countries. According to a recent systematic review, there are no well-designed trials in first-trimester pregnancies that provide consolidated evidence on what is the best first-trimester abortion treatment method, and there are different studies that have tried to demonstrate cost reduction with contradictory results.</p></div><div><h3>Material and methods</h3><p>An observational, retrospective and longitudinal design study was carried out. 892 patients diagnosed with spontaneous abortion during the first trimester of pregnancy were reviewed, in the period between January 2013 and December 2016.</p><p>In our study, we wanted to evaluate the efficacy of vaginal misoprostol as a medical treatment for spontaneous abortion in the first trimester, in comparison with obstetric curettage-evacuator, and to quantify the difference in the costs of both procedures through a cost minimization study. costs.</p></div><div><h3>Results</h3><p>Of the 892 recruited patients, medical treatment with misoprostol was performed in 517 (57.95%) and surgical treatment by curettage in 375 (42.05%).</p><p>The effectiveness of medical treatment was 82% (426/517). With respect to surgical treatment the effectiveness of 100%. The success rate of medical treatment was higher in the subgroup of patients with incomplete abortion (92.9%), compared to the anembryonic gestation (85.7%) and delayed abortion (78.2%) groups.</p></div><div><h3>Conclusions</h3><p>The medical treatment of abortion is a safe management and accepted by the patients. The adequate selection of candidate patients leads to an increase in the success rate and a decrease in costs. In our study, an important total saving of €576,847.92 (37.14%) with respect to surgical treatment will be reduced. Given that the effectiveness is comparable and patient satisfaction is high, although it could be improved, we believe that with adequate information and homogenization of the applied treatment, it is safe.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"51 2","pages":"Article 100934"},"PeriodicalIF":0.1,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139100576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estudio de la microbiota vaginal en los resultados de la terapia de reproducción asistida 阴道微生物群对辅助生殖疗法结果的影响研究。
IF 0.1 Q4 Medicine Pub Date : 2023-12-23 DOI: 10.1016/j.gine.2023.100930
J. Rodríguez Sánchez-Reyman, P. Luque González, M. Pineda Mateo

The microbiome of the female genital tract is essential to maintenance a healthy environment. The normal vaginal microbiota is defined by the abundance of Lactobacillus. These microbes confer the host vagina protection from potentially pathogenic microorganisms that may cause urinary tract infections and sexually transmitted diseases. Changes in the vaginal microbiota due to inherent factors, such as age or menstrual period, or external factors like sexual activity or pregnancy, can lead to microbial dysbiosis and the development of pathologies in relation of reduced rates of conception. It has also been suggested that vaginal microbiota may play a key role in the success of assisted reproductive therapies. The objective of this review is to identify and evaluate trials of the vaginal microbiota role in women's health and human reproduction.

女性生殖道的微生物群对维持健康环境至关重要。正常的阴道微生物群由大量乳酸杆菌构成。这些微生物能保护阴道宿主免受可能导致尿路感染和性传播疾病的潜在病原微生物的侵害。由于年龄或月经期等内在因素,或性行为或怀孕等外在因素,阴道微生物群发生了变化,可能导致微生物菌群失调,出现与受孕率降低有关的病变。也有人认为,阴道微生物群可能在辅助生殖疗法的成功中扮演着关键角色。本综述旨在确定和评估有关阴道微生物群在妇女健康和人类生殖中作用的试验。
{"title":"Estudio de la microbiota vaginal en los resultados de la terapia de reproducción asistida","authors":"J. Rodríguez Sánchez-Reyman,&nbsp;P. Luque González,&nbsp;M. Pineda Mateo","doi":"10.1016/j.gine.2023.100930","DOIUrl":"https://doi.org/10.1016/j.gine.2023.100930","url":null,"abstract":"<div><p>The microbiome of the female genital tract is essential to maintenance a healthy environment. The normal vaginal microbiota is defined by the abundance of <em>Lactobacillus</em>. These microbes confer the host vagina protection from potentially pathogenic microorganisms that may cause urinary tract infections and sexually transmitted diseases. Changes in the vaginal microbiota due to inherent factors, such as age or menstrual period, or external factors like sexual activity or pregnancy, can lead to microbial dysbiosis and the development of pathologies in relation of reduced rates of conception. It has also been suggested that vaginal microbiota may play a key role in the success of assisted reproductive therapies. The objective of this review is to identify and evaluate trials of the vaginal microbiota role in women's health and human reproduction.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"51 2","pages":"Article 100930"},"PeriodicalIF":0.1,"publicationDate":"2023-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139033778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinica e Investigacion en Ginecologia y Obstetricia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1